A prospective observational study of combinatorial abiraterone (AA) and radical radiotherapy (RT) in node-positive (N+) prostate cancer (PCa). Disease progression at 2 years Held out test set 0.96 ...
This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback